Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 101 - 120 out of 500 displayed.
«  1  2  3  4  5 6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Coherus BioSciences to Report Third Quarter 2018 Financial Results on November 8th

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Coherus BioSciences

OncoMed Announces Interim Phase 1b Results for Navicixizumab and Paclitaxel Combination Therapy in Platinum-resistant Ovarian Cancer

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  OncoMed Pharmaceuticals, Inc.

Opiant Pharmaceuticals to Participate in Opioid Panel at the BARDA Industry Day

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Opiant Pharmaceuticals, Inc.

Inovio Presents Progression Free Survival & PSA Doubling Time Improvements in Prostate Cancer Patients Treated with INO-5150

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Inovio Pharmaceuticals Inc.

Allena Pharmaceuticals Presents Preclinical Data Demonstrating Normalized Urine Uric Acid Excretion and Plasma Urate Reduction Following Treatment with ALLN-346

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Allena Pharmaceuticals, Inc.

Results from Celtaxsys’ Acebilustat Phase 2 Trial in Cystic Fibrosis Patients Showing Clinically Meaningful Improvement in Pulmonary Exacerbations Presented at the North American Cystic Fibrosis Conference  

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Celtaxsys, Inc. | Celtaxsys Aus Pty Limited

Relypsa Announces Presentation of New Clinical and Real-World Analyses of Veltassa® at AMCP Nexus 2018

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Relypsa, Inc.

Dentsply Sirona to Host Third Quarter 2018 Conference Call on November 8th

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Dentsply Sirona

Sharp Rees-Stealy Medical Group leverages Allscripts EHR to achieve HIMSS Analytics O-EMRAM Stage 7

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  ALLSCRIPTS

Nuvectra® to Report Third Quarter 2018 Financial Results on October 29, 2018

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Nuvectra Corporation

Arbutus Names New Members to its Board of Directors

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Arbutus Biopharma Corporation

VistaGen Therapeutics to Present at Credit Suisse 27th Annual Healthcare Conference on Wednesday, November 14, 2018

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  VistaGen Therapeutics, Inc.

Resverlogix Announces Participation at Premier Kidney, Alzheimer’s Disease and Cardiovascular Conferences

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Resverlogix Corp.

Hemispherx Outlines Ampligen Combination Therapy Clinical Study Strategy for the Treatment of Multiple Cancers in Letter to Stockholders

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Hemispherx BioPharma

Corvus Pharmaceuticals Announces New Data on Adenosine Gene Signature Biomarker Associated with Patient Response to CPI-444 at European Society for Medical Oncology (ESMO) 2018 Congress

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Corvus Pharmaceuticals, Inc.

Transactions under Novozymes’ stock buyback program

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Novozymes A/S

Cybrexa Therapeutics Expands Scientific Advisory Board Ahead of IND Filing

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Cybrexa Therapeutics

Novo Nordisk A/S - Share repurchase programme

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Novo Nordisk A/S

Kura Oncology Presents Update on Positive Phase 2 Trial of Tipifarnib in HRAS Mutant HNSCC and Preliminary Results in HRAS Mutant SCC

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Kura Oncology, Inc.

Clients save Millions in Drug Spend through the use of Innovative Pharmacy Analytics for Hospitals and Health Systems

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
«  1  2  3  4  5 6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑